Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...

A network of nerves similar to wires runs all through the human body, from the tips of your fingers and toes, through your back inside the spinal cord and up to your brain. Specialized pain receptors ...

Neuropathy leads to sensory loss and increased risk of fall. Here, the authors design a wearable non-invasive neuroprosthesis that restores lost sensations and improves gait.